Dodge & Cox – BMRN history
- Issuer:
- BioMarin Pharmaceutical, Inc.
- Quarters tracked:
- 14 (Q4 2023 → Q1 2026)
- Current shares:
- 14,561,759
- Current value:
- $822.59M
- Peak shares:
- 15,108,310 (Q2 2025)
- Overall change:
- +4%
| Quarter | Shares | Value | $/Share | Share Δ | Δ% |
|---|---|---|---|---|---|
| Q1 2026 | 14,561,759 | $822.59M | $56.49 | -10,625 | 0% |
| Q4 2025 | 14,572,384 | $866.04M | $59.43 | -114,417 | -1% |
| Q3 2025 | 14,686,801 | $795.44M | $54.16 | 0 | 0% |
| Q3 2025 | 14,686,801 | $795.44B | $54160.00 | -421,509 | -3% |
| Q2 2025 | 15,108,310 | $830.50M | $54.97 | 0 | 0% |
| Q2 2025 | 15,108,310 | $830.50B | $54970.00 | +153,070 | +1% |
| Q1 2025 | 14,955,240 | $1.06B | $70.69 | 0 | 0% |
| Q1 2025 | 14,955,240 | $1057.19B | $70690.00 | +209,005 | +1% |
| Q4 2024 | 14,746,235 | $969.27B | $65730.00 | 0 | 0% |
| Q4 2024 | 14,746,235 | $969.27M | $65.73 | +847,917 | +6% |
| Q3 2024 | 13,898,318 | $976.91M | $70.29 | -32,175 | 0% |
| Q2 2024 | 13,930,493 | $1.15B | $82.33 | -62,450 | 0% |
| Q1 2024 | 13,992,943 | $1.22B | $87.34 | -1,120 | 0% |
| Q4 2023 | 13,994,063 | $1.35B | $96.42 | — | NEW |